Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea flag South Korea · Delayed Price · Currency is KRW
27,100
-300 (-1.09%)
Apr 29, 2026, 9:50 AM KST

Ildong Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
863,3211,213,061328,764502,483764,721799,187
Market Cap Growth
175.71%268.98%-34.57%-34.29%-4.31%77.78%
Enterprise Value
941,7651,310,725467,886480,579872,139869,595
Last Close Price
27400.0038245.4511692.1818039.9328361.2433377.85
PE Ratio
29.2543.85----
Forward PE
21.0614.7614.7614.7614.7614.76
PS Ratio
1.522.140.540.841.201.43
PB Ratio
3.524.941.982.803.754.79
P/TBV Ratio
3.865.422.483.754.967.37
P/FCF Ratio
162.77228.7018.67---
P/OCF Ratio
45.5664.0111.62---
PEG Ratio
-0.860.860.860.860.86
EV/Sales Ratio
1.662.310.760.801.371.55
EV/EBITDA Ratio
23.4432.8512.52---
EV/EBIT Ratio
53.4975.6740.93---
EV/FCF Ratio
177.56247.1226.56---
Debt / Equity Ratio
0.590.591.241.191.021.36
Debt / EBITDA Ratio
3.623.625.50---
Debt / FCF Ratio
27.2327.2311.67---
Net Debt / Equity Ratio
0.320.320.730.730.630.43
Net Debt / EBITDA Ratio
1.991.993.23-5.24-2.92-2.85
Net Debt / FCF Ratio
14.9814.986.85-2.64-1.97-2.75
Asset Turnover
0.980.981.020.950.940.85
Inventory Turnover
3.693.694.424.234.443.97
Quick Ratio
0.510.510.520.410.440.59
Current Ratio
0.990.990.920.690.910.84
Return on Equity (ROE)
11.51%11.51%-7.17%-42.25%-76.68%-47.91%
Return on Assets (ROA)
1.86%1.86%1.19%-5.27%-6.75%-5.17%
Return on Invested Capital (ROIC)
3.95%4.23%3.82%-16.60%-25.79%-18.97%
Return on Capital Employed (ROCE)
5.00%5.00%3.60%-19.80%-21.30%-15.50%
Earnings Yield
3.20%2.28%-1.39%-15.71%-18.52%-12.48%
FCF Yield
0.61%0.44%5.36%-9.91%-8.55%-3.25%
Dividend Yield
0.71%0.52%----
Payout Ratio
0.22%0.22%----
Buyback Yield / Dilution
-10.01%-10.01%-3.34%-2.61%-10.76%0.00%
Total Shareholder Return
-9.30%-9.49%-3.34%-2.61%-10.76%0.00%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.